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BACKGROUND
• The optimal length of hospital stay for patients with an uncomplicated acute coronary syndrome is still 
not well defined.1
• Although not corroborated by any guideline, it is current practice an extent of 5-7 days of hospitalization.2
• European and American cardiovascular societies recognized a need to better define the appropriate 
length hospital stay, suggesting the use of prognostic tools to accurately identify low-risk patients who can 
be safely discharged within 72 hours.1,3,4
We aimed to evaluate the safety of an early discharge in selected low risk patients (pts) and also 
to identify predictors of longer hospital stay in this population.
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METHODS
• For each group we compared clinical features and adverse events. 
• Primary endpoint was 1 and 6-month mortality; follow-up was completed in 98% of patients
2531 patients  admitted 
with ACS from




pts with longer hospital 
length stay (> 4 days)
(n=206; 46.7%)
Group 2:
pts with shorter hospital 
length stay (≤ 4 days)
(n=233; 53.3%) 
Four characteristics:
1. No signs of heart failure on admission;
2. Estimated glomerular filtration rate > 60 ml/min;
3. Systolic ventricular ejection fraction ≥ 50%
4. One vessel disease in the cath, excluding left 
main coronary artery disease.
RESULTS
Hospital stay ≥ 4 d Hospital stay < 4 d P
Age (years) 59 ± 11 56 ± 11 0.002
Women (%) 18.7 14.5 0.25


























Hypertension Dyslipidemia Diabetes Smoking
G1
G2
P=0.003 P=0.57 P=0.126 P=0.18
• Cardiovascular Risk Factors
Hospital stay ≥ 4 d Hospital stay < 4 d P













Hospital stay ≥ 4 d Hospital stay < 4 d p
Aspirin (%) 99.8 100 0.22
Clopidogrel (%) 98.1 98.3 0.45
Beta-blockers (%) 91.8 89.4 0.42
ACE-Inhibitors (%) 84.1 89.4 0.09
Statins (%) 99.5 99.6 0.32
Inotropics (%) 1.4 0.0 0.103
Diuretics (%) 8.6 3.5 0.043




Revascularization (%) 84.1 89.4 0.121
CABG (%) 8.8 0.0 <0.001
• In hospital medical treatment and procedures
Hospital stay ≥ 4 d Hospital stay < 4 d p
Acute heart failure (%) 5.3 1.7 0.035
Reinfarction (%) 2.9 0.4 0.45
Ventricular arrhythmias (%) 4.3 1.4 0.63
New-onset AF (%) 5.8 2.6 0.096
High Heart block (%) 4.8 2.6 0.21
Contrast nephropathy (%) 25.1 19.2 0.16
≥ 2gr haemoglobin falling (%) 14.9 12.8 0.58
Respiratory infection (%) 1.5 0.4 0.34






Age > 60 years old 2.06 1.32 2.23 0.002
Previous diagnosed AF 3.69 1.11 12.22 0.033
CABG 11.14 2.44 50.85 0.002
Glycoprotein IIb/IIIa
inhibitors 
2.30 1.17 4.52 0.016
Acute heart failure 2.39 0.69 8.22 0.167
Hypertension 1.38 0.87 2.18 0.17





























• Our low risk acute coronary syndrome patients were safely discharged after four days of hospitalization.
• Four days of hospital stay were necessary to introduce prognostic modification drugs, educate and promote 
changing in life styles.
• The predictors of longer hospital length stay identified were age > 60 years, previous diagnosed atrial 
fibrillation, performing CABG and treatment with glycoprotein IIb/IIIa inhibitors.
• This was a single-center, retrospective analysis, subject to inherent selection biases and sample size-related 
statistical limitations. 
Limitations
